This legislation, titled the Precision Brain Health Research Act of 2026, significantly modifies the Department of Veterans Affairs' Precision Medicine for Veterans Initiative. It expands the initiative's focus to include repetitive low-level blast exposure and dementia , aiming to broaden the understanding and treatment of these critical conditions affecting veterans. A key provision establishes a mandatory data-sharing partnership between the VA and the Department of Defense within one year, integrating relevant DoD data from various military sources into an open platform. The VA Secretary is required to report biennially to Congress on this partnership, detailing new therapies developed and evaluations. The bill mandates extensive research into repetitive low-level blast injuries, encompassing big-data assessments, large-scale implementation studies, and translational research on growth hormone replacement therapy. It also requires quality improvement studies for diagnosis and care, and directs the VA to engage the National Academies for biomarker validation, with biennial reports. To support these efforts, the legislation authorizes an annual appropriation of $5,000,000 for the initiative from FY2025 through FY2030, alongside regular VA reports to Congress on overall progress and recommendations.